Literature DB >> 10876219

Prevention of paraplegia in pigs by selective segmental artery perfusion during aortic cross-clamping.

S A Meylaerts1, P De Haan, C J Kalkman, J Jaspers, I Vanicky, M J Jacobs.   

Abstract

PURPOSE: During thoracoabdominal aortic aneurysm repair, a prolonged interruption of the spinal cord blood supply can result in irreversible spinal cord damage. The aim of this study was to investigate whether selective segmental artery perfusion during aortic clamping could prevent paraplegia in pigs.
METHODS: Specially designed segmental artery perfusion catheters, which could be attached to an extracorporeal bypass graft system, were used. In experiment I (n = 10), it was assessed whether selective segmental artery perfusion could reverse electrophysiologic evidence of spinal cord ischemia and maintain transcranial motor evoked potentials (tc-MEPs) during 60 minutes of aortic cross-clamping. The abdominal aorta, containing critical segmental arteries, was bypassed through use of an aortoaortic bypass graft system. After the disappearance of tc-MEPs, an aortotomy was followed by selective segmental artery perfusion. In experiment II (n = 10), the aim was to determine whether selective segmental artery perfusion could prevent paraplegia. In five animals (group A), aortic cross-clamping was followed by selective segmental artery perfusion; five control animals (group B) underwent segmental artery blockade only. Postoperative hind limb function and spinal cord histopathology were evaluated on the third postoperative day.
RESULTS: In experiment I, tc-MEPs disappeared within 3.7 +/- 3.7 minutes after cross-clamping and returned in all animals in 8.5 +/- 5.3 minutes after selective perfusion. During the study period, tc-MEP amplitudes recovered to a median of 49% (range, 28%-113%) of baseline values. Total bypass graft flow was 880 +/- 294 mL/min, of which 184 +/- 54 mL/min was directed to the selective perfusion catheters. The flow in individual catheters was 52 +/- 13 mL/min. In experiment II, all perfused animals demonstrated normal hind limb function, whereas four of five control animals were paraplegic on day 3 (P =.04) In the perfused animals, histopathologic examination showed either no spinal cord damage or eosinophilic neurons only, whereas in paraplegic controls there was infarction in large areas of the cord (P <.0001).
CONCLUSION: In pigs, selective segmental artery perfusion can provide sufficient spinal cord blood flow to prevent paraplegia resulting from 60 minutes of aortic clamping, as shown by clinical outcomes and histopathologic examination.

Entities:  

Mesh:

Year:  2000        PMID: 10876219     DOI: 10.1067/mva.2000.107571

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  10 in total

1.  Emergency surgery of the abdominal aorta in a porcine model: two sequential experiments.

Authors:  Francisco S Lozano; José M Rodríguez; Francisco J García-Criado; Jose R Gonzalez-Porras; Fermin M Sanchez-Guijo; Pilar Sanchez-Conde; Jose E García-Sanchez
Journal:  World J Surg       Date:  2008-04       Impact factor: 3.352

2.  Left axillary arterial perfusion for cerebrospinal protection in proximal descending aortic aneurysm.

Authors:  Masato Tochii; Motomi Ando; Yasushi Takagi; Mitsuru Yamashita; Ryo Hoshino; Kiyotoshi Akita
Journal:  Gen Thorac Cardiovasc Surg       Date:  2008-12-16

Review 3.  Current strategies for spinal cord protection during thoracic and thoracoabdominal aortic aneurysm repair.

Authors:  Hideyuki Shimizu; Ryohei Yozu
Journal:  Gen Thorac Cardiovasc Surg       Date:  2011-03-30

4.  Nrf2 activation in astrocytes contributes to spinal cord ischemic tolerance induced by hyperbaric oxygen preconditioning.

Authors:  Jiajun Xu; Guoyang Huang; Kun Zhang; Jinchuan Sun; Tao Xu; Runping Li; Hengyi Tao; Weigang Xu
Journal:  J Neurotrauma       Date:  2014-07-11       Impact factor: 5.269

5.  Comparison of carbamylated erythropoietin-FC fusion protein and recombinant human erythropoietin during porcine aortic balloon occlusion-induced spinal cord ischemia/reperfusion injury.

Authors:  Florian Simon; Angelika Scheuerle; Michael Gröger; Brigitta Vcelar; Oscar McCook; Peter Möller; Michael Georgieff; Enrico Calzia; Peter Radermacher; Hubert Schelzig
Journal:  Intensive Care Med       Date:  2011-07-16       Impact factor: 17.440

6.  Effects of a cantaloupe melon extract/wheat gliadin biopolymer during aortic cross-clamping.

Authors:  Jochen Kick; Balázs Hauser; Hendrik Bracht; Maura Albicini; Sükrü Oter; Florian Simon; Ulrich Ehrmann; Catherine Garrel; Jörn Sträter; Uwe B Brückner; Xavier M Leverve; Hubert Schelzig; Günter Speit; Peter Radermacher; Claus-Martin Muth
Journal:  Intensive Care Med       Date:  2007-01-20       Impact factor: 17.440

7.  Histological Findings After Aortic Cross-Clamping in Preclinical Animal Models.

Authors:  Hamdy Awad; Alexander Efanov; Jayanth Rajan; Andrew Denney; Bradley Gigax; Peter Kobalka; Hesham Kelani; D Michele Basso; John Bozinovski; Esmerina Tili
Journal:  J Neuropathol Exp Neurol       Date:  2021-10-26       Impact factor: 3.685

8.  The selective poly(ADP)ribose-polymerase 1 inhibitor INO1001 reduces spinal cord injury during porcine aortic cross-clamping-induced ischemia/reperfusion injury.

Authors:  Christian Maier; Angelika Scheuerle; Balázs Hauser; Hubert Schelzig; Csaba Szabó; Peter Radermacher; Jochen Kick
Journal:  Intensive Care Med       Date:  2007-03-15       Impact factor: 17.440

9.  Treatment for thoracoabdominal aortic aneurysm by fenestrated endovascular aortic repair with physician-modified stent graft.

Authors:  Xin Yang; Xiang-Chen Dai; Jie-Chang Zhu; Yu-Dong Luo; Hai-Lun Fan; Zhou Feng; Yi-Wei Zhang; Fan-Guo Hu
Journal:  J Int Med Res       Date:  2018-03-14       Impact factor: 1.671

10.  Intravenous hydrogen sulfide does not induce neuroprotection after aortic balloon occlusion-induced spinal cord ischemia/reperfusion injury in a human-like porcine model of ubiquitous arteriosclerosis.

Authors:  Andre Bredthauer; Karla Lehle; Angelika Scheuerle; Hubert Schelzig; Oscar McCook; Peter Radermacher; Csaba Szabo; Martin Wepler; Florian Simon
Journal:  Intensive Care Med Exp       Date:  2018-10-24
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.